TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -90.3% | 55 | -71.1% | 0.00% | – |
| Q2 2023 | $4,720 | +66.0% | 190 | +0.5% | 0.00% | – |
| Q1 2023 | $2,843 | -58.9% | 189 | -67.7% | 0.00% | – |
| Q4 2022 | $6,920 | -99.8% | 585 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $3,449,000 | -63.7% | 582,421 | -73.9% | 0.01% | -61.5% |
| Q2 2022 | $9,499,000 | +27.6% | 2,234,979 | +185.6% | 0.03% | +52.9% |
| Q1 2022 | $7,442,000 | +2218.4% | 782,533 | +12576.7% | 0.02% | +1600.0% |
| Q4 2020 | $321,000 | -71.2% | 6,173 | -85.2% | 0.00% | -66.7% |
| Q3 2020 | $1,115,000 | -85.6% | 41,652 | -89.5% | 0.00% | -84.2% |
| Q2 2020 | $7,753,000 | +746.4% | 398,008 | +327.7% | 0.02% | +533.3% |
| Q1 2020 | $916,000 | +45700.0% | 93,051 | +46425.5% | 0.00% | – |
| Q4 2019 | $2,000 | -99.8% | 200 | -99.7% | 0.00% | -100.0% |
| Q2 2018 | $982,000 | +20.2% | 74,643 | +29.7% | 0.00% | +50.0% |
| Q1 2018 | $817,000 | – | 57,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |